Inbiomotion
Pre-clinicalBreast cancer is the most commonly diagnosed cancer for women, and still remains the leading cause of cancer death in women worldwide. Most deaths are due to metastatic spread rather than to the primary tumor.Currently there is a growing unmet need for biomarkers for effective patient management to identify patients that will benefit an adjuvant treatment to prevent disease spread.
About
Breast cancer is the most commonly diagnosed cancer for women, and still remains the leading cause of cancer death in women worldwide. Most deaths are due to metastatic spread rather than to the primary tumor.Currently there is a growing unmet need for biomarkers for effective patient management to identify patients that will benefit an adjuvant treatment to prevent disease spread.
Funding History
2Total raised: $25M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile